Avicanna Announces Repayment of Debentures
TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the devel…